KTTA Competitors & Alternatives

Compare Pasithea Therapeutics Corp with similar stocks in the same industry

Biotechnology

KTTA

Main Stock
$0.48
-0.48%
Tradestie Score
40
Market Cap
$5.73M
Revenue Growth
15.0%
Analyst Upside
+735.6%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: monoclonal antibodies, small molecule synthesis
Major Customers 2
academic research institutions future pharma partners
Critical Suppliers 2
CROs antibody manufacturers
Direct Ecosystem Rivals 2

Top Competitors

216 stocks in Biotechnology
Company Price Market Cap P/E Score Action
CLYM Climb Bio, Inc. Common Stock
$9.19
-0.97%
$133.50M - 42 Compare
SRZN Surrozen, Inc. Common
$28.46
-7.21%
$117.07M - 34 Compare
ANRO Alto Neuroscience Inc.
$25.37
-4.30%
$110.20M - 44 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.31
+0.76%
$84.52M - 40 Compare
IMMX Immix Biopharma, Inc. Common Stock
$6.96
-1.14%
$67.94M - 48 Compare
BFRI Biofrontera Inc. Common Stock
$0.53
-7.02%
$10.88M - 42 Compare
ISPC iSpecimen Inc. Common Stock
$0.46
-13.58%
$10.10M - 40 Compare
ENSC Ensysce Biosciences, Inc. Common Stock
$0.36
-0.17%
$7.21M - 52 Compare
QNRX Quoin Pharmaceuticals, Ltd. American Depositary Shares
$3.28
-2.35%
$4.25M 7.6 44 Compare
PTPI PTPI
- - - - Compare

Data updated: Nov 22, 2026 | Industry: Biotechnology (SIC 2834)

216 stocks in this industry